Q1 EARNINGS: Medtronic makes TAVI gains
This article was originally published in Clinica
Executive Summary
Medtronic’s first-quarter results were an improvement over a mixed Q4, beating analyst expectations – but only just. Q1 revenues of $4.27bn were up 5% year-on-year and edged above analyst predictions of $4.25bn; while non-GAAP earnings of $0.93 per diluted share beat consensus of $0.92 and also represented 6% year-on-year growth.